Terminating routine cord blood RhD typing of the newborns to guide postnatal anti-D immunoglobulin prophylaxis based on the results of fetal RHD genotyping.

Monica Stensrud,Mette Silihagen Bævre, Inger Margit Alm, Ho Yi Wong,Ida Herud,Barbora Jacobsen, Dijanne Dicky Jannie Anne de Vos,Helena Eriksson Stjern,Ingvild Hausberg Sørvoll, Janne Brit Barane, Tonje Espeland Bagås,Mona Rasmussen, Norunn Ulvahaug, Vendula Wamstad,Geir Tomter,Cigdem Akalin Akkök

Fetal diagnosis and therapy（2023）

引用 0|浏览2

暂无评分

摘要

Few false negative results support the good analysis quality of fetal RHD genotyping. Routine cord blood RhD typing will therefore be discontinued nationwide and postnatal anti-D immunoglobulin will now be given based on the result of fetal RHD genotyping.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要